Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004153 · ClinicalTrials.gov registry record · NA
Detection of Melanoma Markers in Lymph Nodes or Peripheral Blood of Patients With Melanoma
A NA study, sponsored by University of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 106
- Enrollment target
NCT00004153: Completed NA study, sponsored by University of Chicago.
NCT00004153 is a NA study that has completed, run by University of Chicago. The registered enrollment target is 106 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00004153, a NA study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 106 participants
- Enrollment target
Study Summary
RATIONALE: Diagnostic procedures may improve the ability to detect the presence or recurrence of disease. PURPOSE: Diagnostic trial to detect melanoma markers in the lymph nodes or peripheral blood of patients who have melanoma.
Interventions
- GENETIC reverse transcriptase-polymerase chain reaction
- PROCEDURE sentinel lymph node biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 1998-06 |
| Est. Completion | 2005-01 |
| Phase | NA |
What the finished NCT00004153 record still lists
NCT00004153 is an interventional study that assigns participants to a tested intervention. The registered 106 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 2 interventions - of which reverse transcriptase-polymerase chain reaction is the first listed.
NCT00004153 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00004153 about?
NCT00004153 is a clinical study titled "Detection of Melanoma Markers in Lymph Nodes or Peripheral Blood of Patients With Melanoma". RATIONALE: Diagnostic procedures may improve the ability to detect the presence or recurrence of disease. PURPOSE: Diagnostic trial to detect melanoma markers in the lymph nodes or peripheral blood of patients who have melanoma.
What is the current status of trial NCT00004153?
This trial is currently completed. It is a NA study. The enrollment target is 106 participants. The study started on 1998-06. Estimated completion is 2005-01.
What interventions are being tested in trial NCT00004153?
The interventions under investigation include: reverse transcriptase-polymerase chain reaction (GENETIC), sentinel lymph node biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT00004153?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00004153's enrollment target sits among peer trials
106 830th of 2000 higher than 1,167 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03181048 · 106 participants · NA
Clinical Trial of Concomitant Hip Arthroscopy During PAO
- NCT04682158 · 106 participants · Phase 2
Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma
- NCT04724018 · 106 participants · Phase 1
Sacituzumab Govitecan Plus EV in Metastatic UC
- NCT04798274 · 106 participants · NA
Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia